|
|
Post by morfu on Feb 2, 2017 9:21:51 GMT -5
Just went for my physical and after listening to to various insulin commercials in the waiting room (insulin pump and SGLT) I asked the nurse and the doctor about Afrezza . . . neither had heard the name.
The doctor knew that there was something in the making, but the big one from the past was not so good.. she was not aware it is on the market ..
Both seemed interested to look it up..
Mannkind, you wont sell the product if you dont educate the doctors!
|
|
|
|
Post by kc on Feb 2, 2017 9:36:21 GMT -5
What city or market are you in?
|
|
|
|
Post by morfu on Feb 2, 2017 9:37:52 GMT -5
DC suburbs
|
|
|
|
Post by kc on Feb 2, 2017 9:45:56 GMT -5
That is what is most troubling. An area like DC that is very urban / suburban has a lot of good doctors and a population with insurance coverage needs to get attention. You can't get market penetration on a limited shoestring budget. MannKind needs to be sold to a pharma with the ability to invest in marketing to the doctors and patients. I don't believe they will ever be successful trying to stay independent.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 2, 2017 9:59:32 GMT -5
laughable . complete failure on MNKD commercial organization. |
|
|
|
Post by kc on Feb 2, 2017 10:03:34 GMT -5
laughable . complete failure on MNKD commercial organization. Best to focus on the top 25 to 50 markets where you have density and it makes sales calls easier. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 2, 2017 10:14:13 GMT -5
laughable . complete failure on MNKD commercial organization. Best to focus on the top 25 to 50 markets where you have density and it makes sales calls easier. and the results spread faster too.. in highly populated areas |
|
